Journals / BEYOGLU EYE JOURNAL / 2020 / Cilt: 5 - Sayı: 2

Evaluation of Demographic Features of Eyelid Lesions

Pages
114–117
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The most common site of malignant tumor origin was the lower eyelid, with the exception of sebaceous gland carcinoma.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: This study was an evaluation of demographic and histopathologic features of eyelid lesions.
📊
Key Findings & Data:Methods: The medical records of 261 patients (296 eyelid lesions) who attended a single clinic between 1997 and 2011 were examined retrospectively.
💡
Conclusion & Impact:The most common site of malignant tumor origin was the lower eyelid, with the exception of sebaceous gland carcinoma.
🔬Design:Research Article
📍Scope:2011 Verileri
⚙️Variables:Domain Parameters

Özet

Objectives: This study was an evaluation of demographic and histopathologic features of eyelid lesions. Methods: The medical records of 261 patients (296 eyelid lesions) who attended a single clinic between 1997 and 2011 were examined retrospectively. The incidence of benign and malignant lesions, the pathological classification, and age and sex data were investigated. Results: A total of 204 benign lesions (68.9%) and 92 malignant neoplasms (31.1%) were found. Among these, the most frequently seen types of benign neoplasms were xanthelasma (28.4%), papilloma (14.7%), chalazion (8.8%), nevus (6.4%), moll cyst (5.9%), and capillary hemangioma (4.9%). The most frequently seen malignant neoplasms were basal cell carcinoma (72.8%), squamous cell carcinoma (13%), and sebaceous gland carcinoma (5.4%). The study group was made up of 149 (57%) female patients and 112 (43%) male patients. The majority of benign lesions were seen in women, whereas malignant neoplasms were observed more often in male patients. The mean age of patients with benign lesions and malignant neoplasms was 38.1±21.7 and 62.7±15.3 years, respectively. Benign lesions involved the upper eyelid more frequently than the lower, while malignant lesions were seen more frequently in the lower eyelid, with the exception of sebaceous gland carcinoma. Conclusion: The majority of eyelid lesions were benign and malignant neoplasms were seen more frequently in the older population. Basal cell carcinoma was the most common malignant eyelid tumor. The most common site of malignant tumor origin was the lower eyelid, with the exception of sebaceous gland carcinoma.

🔖

Cite This Article

FAZIL, K., KARSLİOGLU, S., AKBABA, M., BUTTANRİ, I. B., SERİN, D., KARABULUT, G., BEKTASOGLU, D. (2020). Evaluation of Demographic Features of Eyelid Lesions. BEYOGLU EYE JOURNAL, Cilt: 5 - Sayı: 2, 114–117. https://ajindex.com/articles/164587

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Duman R, Yozgat Z, Doğan M, İnan S, Özcan S, Demirciler B, et al. Histopathological Results of the Eyelid Tumors. Acta Oncol Turc 2018;51(1):13–6
  2. Deprez M, Uffer S. Clinicopathological features of eyelid skin tumors. A retrospective study of 5504 cases and review of literature. Am J Dermatopathol 2009;31(3):256–62
  3. Karabulut HH, Yuyucu Karabulut Y, Şenel E, Dölek Y, Uslu A, Kurşun N. Histopathologic and Demographic Features of Eyelid Tumours. Turk J Dermatol 2014;4:197–201
  4. Gökmen Soysal H, Albayrak A. Göz Kapaklarının Primer Malign Tümörleri. T Oft Gaz 2001;31(3):370–7
  5. Kurt A, Mutlu SN, Yener Hİ, Bayram N, Nazlım S. Histopathology Results of Primary Eyelid Tumors. Dicle Med J 2015;42(1):72–7
  6. Chang CH, Chang SM, Lai YH, Huang J, Su MY, Wang HZ, ET AL. Eyelid tumors in southern Taiwan: a 5-year survey from a medical university. Kaohsiung J Med Sci 2003;19(11):549–54
  7. Çevik SG, Yücel E, Çevik M, Mutlu N. Our Histological Results of the Eyelids and Conjunctiva Tumour. Acta Oncol Turc 2015;48(3):114–7
  8. Margo CE. Eyelid tumors: Accuracy of clinical diagnosis. Am J Ophthalmol 1999;128(5):635–6
  9. Huang YY, Liang WY, Tsai CC, Kao SC, Yu WK, Kau HC, et al. Comparison of the Clinical Characteristics and Outcome of Benign and Malignant Eyelid Tumors: An Analysis of 4521 Eyelid Tumors in a Tertiary Medical Center. Biomed Res Int 2015;2015:453091
  10. Xu XL, Li B, Sun XL, Li LQ, Ren RJ, Gao F, ET AL. Eyelid neoplasms in the Beijing Tongren Eye Centre between 1997 and 2006. Ophthalmic Surg Lasers Imaging 2008;39(5):367–72
  11. Tesluk GC. Eyelid lesions: incidence and comparison of benign and malignant lesions. Ann Ophthalmol 1985;17(11):704–7
  12. Onak Kandemir N, Barut F, Bektaş S, Doğan Gün B, Bahadır B, Yurdakan G, et al. Tumors and Tumor-Like Lesions of the Eyelid and Conjunctiva. Turk Patoloji Derg 2009;25(3):112–7
  13. Coroi MC, Roşca E, Muţiu G, Coroi T, Bonta M. Eyelid tumors: Histopathological and Clinical Study Performed in County Hospital of Oradea between 2000-2007. Rom J Morphol Embryol 2010;51(1):111–5
  14. Çağlar Ç, Güney G, Dönmez O, Baş Y, Durmuş M. Histopathology Results of Eyelid Tumors. Turkiye Klinikleri J Ophthalmol 2017;26(1):25–31
  15. Göncü T, Çakmak S, Akal A, Oğuz H. Clinicopathological Features of Benign Eyelid Tumors: A Retrospective Analysis of 101 Cases. Turk J Ophthalmol 2014;44(5):384–7
  16. Kaliki S, Bothra N, Bejjanki KM, Nayak A, Ramappa G, Mohamed A, et al. Malignant Eyelid Tumors in India: A Study of 536